Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway

Our previous studies suggested that salidroside could alleviate hepatic steatosis in type 2 diabetic C57BLKS/Lepr(db) (db/db) mice. The aim of the present study was to evaluate the therapeutic effect of salidroside on high-fat diet- (HFD-) induced nonalcoholic fatty liver disease (NAFLD) by investig...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oxid Med Cell Longev
Autori principali: Zheng, Tao, Yang, Xiaoyan, Li, Wenjin, Wang, Qibin, Chen, Li, Wu, Dan, Bian, Fang, Xing, Shasha, Jin, Si
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6081551/
https://ncbi.nlm.nih.gov/pubmed/30140371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8597897
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi